 
			辅料聚维酮K30对缬沙坦胶囊质量控制的影响
 ({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Impact of the excipient povidone K30 on drug quality control of valsartan capsules
 ({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} | {{custom_citation.content}} 
											{{custom_citation.annotation}}
										 | 
/
| 〈 |  | 〉 |